These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9824634)

  • 1. Antitumor response of genetically engineered IL-2 expression to human esophageal carcinoma cells in mature T cell-defective condition.
    Matsubara H; Koide Y; Sugaya M; Gunji Y; Asano T; Ochiai T; Takegana K; Sakiyama S; Tagawa M
    Int J Oncol; 1998 Dec; 13(6):1217-22. PubMed ID: 9824634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of interleukin-21 and -23 in human esophageal tumors produced antitumor effects in nude mice.
    Shan B; Yu L; Shimozato O; Li Q; Tagawa M
    Anticancer Res; 2004; 24(1):79-82. PubMed ID: 15015579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired immunity in nude mice induced by expression of the IL-2 or IL-4 gene in human pancreatic carcinoma cells and anti-tumor effect generated by in vivo gene transfer using retrovirus.
    Kimura M; Yoshida Y; Narita M; Takenaga K; Takenouchi T; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M
    Int J Cancer; 1999 Aug; 82(4):549-55. PubMed ID: 10404069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of antitumor effect on human esophageal carcinoma cells by the retroviral expression of granulocyte macrophage-colony stimulating factor gene.
    Sugaya M; Tagawa M; Matsubara H; Gunji Y; Takenaga K; Maeda T; Koide Y; Asano T; Ochiai T; Isono K; Sakiyama S
    Int J Oncol; 1998 Feb; 12(2):321-4. PubMed ID: 9458356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice.
    Hirahara N; Nio Y; Sasaki S; Minari Y; Takamura M; Iguchi C; Dong M; Yamasawa K; Tamura K
    Oncology; 2001; 61(1):79-89. PubMed ID: 11474253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroporation-mediated transfer of cytokine genes into human esophageal tumors produces anti-tumor effects in mice.
    Matsubara H; Gunji Y; Maeda T; Tasaki K; Koide Y; Asano T; Ochiai T; Sakiyama S; Tagawa M
    Anticancer Res; 2001; 21(4A):2501-3. PubMed ID: 11724313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of tumorigenicity of human pancreatic carcinoma cells engineered to produce interleukin-2 or interleukin-4 in nude mice: a potentiality for cancer gene therapy.
    Kimura M; Tagawa M; Takenaga K; Kondo F; Yamaguchi T; Saisho H; Nakagawara A; Sakiyama S
    Cancer Lett; 1998 Jun; 128(1):47-53. PubMed ID: 9652792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired tumorigenicity of IL-4-producing murine neuroblastoma cells in immunodeficient nude mice.
    Yoshida H; Enomoto H; Miyauchi M; Takenaga K; Tanabe M; Ohnuma N; Sakiyama S; Tagawa M
    Int J Oncol; 1998 May; 12(5):1067-71. PubMed ID: 9538130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of tumorigenicity of human breast cancer cells engineered to produce IL-2, IL-4 or GM-CSF in nude mice.
    Maeda T; Matsubara H; Sugaya M; Miyazawa Y; Gunji Y; Ochiai T; Sakiyama S; Tagawa M
    Int J Oncol; 1999 Nov; 15(5):943-7. PubMed ID: 10536177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunity.
    Fakhrai H; Shawler DL; Gjerset R; Naviaux RK; Koziol J; Royston I; Sobol RE
    Hum Gene Ther; 1995 May; 6(5):591-601. PubMed ID: 7578396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
    Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals.
    Chiyo M; Shimozato O; Yu L; Kawamura K; Iizasa T; Fujisawa T; Tagawa M
    Int J Cancer; 2005 Jun; 115(3):437-42. PubMed ID: 15688376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of peritoneal dissemination of murine colon carcinoma cells by administrating retrovirus harboring IL-2 gene.
    Gunji Y; Tasaki K; Tagawa M; Matsubara H; Takenaga K; Suzuki T; Asano T; Ochiai T; Isono K; Sakiyama S
    Cancer Gene Ther; 1998; 5(6):339-43. PubMed ID: 9917087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer gene therapy: transgenic immunotherapy.
    Su N; Ojeifo JO; MacPherson A; Zwiebel JA
    Breast Cancer Res Treat; 1994; 31(2-3):349-56. PubMed ID: 7881111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired tumorigenicity of human pancreatic cancer cells retrovirally transduced with interleukin-12 or interleukin-15 gene.
    Yoshida Y; Tasaki K; Miyauchi M; Narita M; Takenaga K; Yamamoto H; Yaaguchi T; Saisho H; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2000 Feb; 7(2):324-31. PubMed ID: 10770643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The protocol of clinical trial and basic experiments for esophageal cancer using gene transduction].
    Matsubara H; Ochiai T
    Nihon Rinsho; 2000 Sep; 58(9):1935-43. PubMed ID: 11004829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
    Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS
    Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of wild-type p53 gene confers increased sensitivity to radiation and chemotherapeutic agents in human esophageal carcinoma cells.
    Matsubara H; Kimura M; Sugaya M; Koide Y; Gunji Y; Takegana K; Asano T; Ochiai T; Isono K; Sakiyama S; Tagawa M
    Int J Oncol; 1999 Jun; 14(6):1081-5. PubMed ID: 10339661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells.
    Wang YQ; Ugai S; Shimozato O; Yu L; Kawamura K; Yamamoto H; Yamaguchi T; Saisho H; Tagawa M
    Int J Cancer; 2003 Jul; 105(6):820-4. PubMed ID: 12767068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells.
    Tasaki K; Yoshida Y; Maeda T; Miyauchi M; Kawamura K; Takenaga K; Yamamoto H; Kouzu T; Asano T; Ochiai T; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2000 Feb; 7(2):247-54. PubMed ID: 10770633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.